Background. Invasive fungal infections pose a serious threat to hospitalized patients worldwide. In particular, the prevalence of clusters of nosocomial infection among patients with candidemia remains unknown. The aim of this study was to investigate the molecular epidemiology of candidemia in a nationwide setting in Iceland during a 16-year period.
Invasive fungal infections, caused by yeasts of the Candida genus, have emerged as a serious threat to hospitalized patients worldwide in recent decades [1] [2] [3] . In particular, candidemia is associated with mortality rates as high as 49% and an excessive length of hospital stay [4, 5] . Invasive nosocomial fungal infections are a cause of growing concern in the hospital environment. A population-based study in Iceland demonstrated a 3.5-fold increase in the incidence of candidemia between 1980 and 1999, and almost all of these infections were nosocomial [6, 7] . Nosocomial fungal infections can originate from endogenous strains brought into the hospital environment by the patients themselves [8] ; alternatively, exogenous strains can be transmitted to the patients from contaminated infusates, biomedical devices, and the hands of health care workers [9] [10] [11] [12] .
Advances in molecular biology over the past 2 decades have led to the development of molecular techniques for genotyping clinical isolates of human pathogenic yeasts; these advances have facilitated epidemiological studies [13, 14] . Among these new techniques, PCR fingerprinting and random amplification of polymorphic DNA are widely used [15, 16] . They have high discriminatory power for related and unrelated isolates of clinically relevant Candida species, especially when a number of single primers are used, and strong concordance with results of other established methods, such as multilocus enzyme electrophoresis, Ca3 Southern hybridization probe techniques, and multilocus sequence typing [17, 18] . PCR-based fin-gerprinting methods have proved useful for hospital epidemiology-in particular, for investigating infection clusters of invasive candidiasis in hospitals [19, 20] .
Many molecular epidemiological studies of candidemia have been performed to investigate or confirm suspected outbreaks in single hospital departments or in 1 hospital [12, [19] [20] [21] [22] , but the overall prevalence of nosocomial clustering in patients with candidemia remains unknown. Iceland is well suited for studies of this nature because of the high quality and accessibility of demographic and medical data and the centralized storage of all fungal bloodstream isolates (BSIs), which date to 1991. The aim of this long-term, population-based study was to use PCR fingerprinting to study the genetic relatedness of all available clinical BSIs of Candida species in Iceland during a 16-year period, 1991-2006, and to quantify the potential contribution of nosocomial outbreaks in the overall context of candidemia. In addition, we propose criteria for definition of nosocomial clustering of candidemia.
METHODS

Setting.
Iceland is a 103,000-km 2 island in the North Atlantic, midway between Europe and North America; the population was 255,866 in the beginning of 1991 and 307,672 at the end of 2006. Currently, 2 university hospitals and 14 community hospitals exist in the country. During most of the study period, there were 3 adult intensive care units (ICUs) and 1 neonatal ICU (NICU) in the country. Three clinical microbiology laboratories processed blood cultures from all hospitals, with 1 serving as a reference laboratory for the entire country. This study was approved by the National Bioethics Committee of Iceland and the Data Protection Authority of Iceland.
Case definitions and collection of data. All patients in Iceland who had yeast isolated from blood specimens during the period 1 January 1991 through 31 December 2006 were identified retrospectively by a nationwide search of microbiology databases. Information was obtained about patient age, sex, location of hospital, hospital ward at the time when blood samples were obtained for culture, and original species identification. With use of hospital records and the national population registry of Iceland (http://www.statice.is), we calculated the proportion of deaths among patients with candidemia within 7 and 30 days, respectively, after the blood sample was obtained for culture. An episode of candidemia was defined as у1 blood culture positive for Candida species. Episodes were considered to be separate if they occurred at least 1 month apart [23] or were caused by different Candida species. With regard to case fatality, patients with polymicrobial candidemia were excluded from analyses comparing cluster-associated and sporadic infections.
Microbiology. All obtainable fungal BSIs were collected from hospital laboratories throughout Iceland, where they had been stored at Ϫ70ЊC since the time of culturing. In total, 217 isolates from 1 January 1991 through 31 December 2006 were viable and were thus available for further study. Two isolates cultured in 1990 were also included. The isolates were subcultured on Sabouraud agar (Oxoid). Species identification was based on germ-tube production, culture on CHROMagar (Hardy Diagnostics), and the API id32C system (bioMérieux).
PCR fingerprinting. Genomic DNA was extracted from each isolate in accordance with a protocol described by Xu et al. [16] and was stored at Ϫ20ЊC. DNA was amplified by arbitrarily primed PCR with use of 4 single primers-M13, (GACA) 4 , PA03, and T3B-that have been used for genotyping Candida isolates and are described in detail elsewhere [15, 16] . Amplifications were performed in volumes of 25 mL in a 200-mL Ready-to-Go-PCR tube (Amersham Biosciences) that contained ∼20 ng of genomic DNA and primer at a final concentration of 0.8 mM. All PCRs were performed in a Touchgene Gradient thermal cycler (Techne) as described by Xu et al. [16] , with minor alterations. Amplification products were separated by electrophoresis on 1% agarose gels with 1ϫ TBE buffer (Trisborate-EDTA [pH 8]) for 150 min at 6 V/cm. Amplicons were stained with ethidium bromide and were photographed digitally under ultraviolet light (ChemiImager; Alpha Innotech).
Reproducibility assessment. Genomic DNA from a Candida albicans ATCC 90028 strain was included in each arbitrarily primed PCR run. PCR fingerprinting patterns of the ATCC 90028 strain were compared to assess reproducibility, and fingerprinting results from each run were included only if the ATCC 90028 fingerprint was consistent with those of previous runs.
Fingerprinting analysis and cluster definitions. The electrophoretic bands were sized and scored manually and with BioNumerics, version 4.61 (Applied Maths), with use of a position-tolerance setting of 2%. Fingerprinting patterns were clustered, and dendrograms were generated using the Dice coefficient and the unweighted-pair group method with use of average linkages. Epidemiologically related isolates were clustered using 2 potential cutoff values: 100% and у90% relatedness. To evaluate the proportion of infections caused by clustered isolates, a nosocomial cluster was defined as isolation of closely related isolates (у90%) from у2 patients in the same ward or at the same hospital within a period of 90 days. Patients with polymicrobial candidemia were excluded from these calculations.
Statistical analysis. Information about national demographic characteristics was obtained at the national population registry of Iceland. These data were used to calculate the incidence (cases per 100,000 population per year) of candidemia in Iceland from 1991 through 2006. Information about admissions to the 2 university hospitals for each study year was obtained from annual hospital reports. The incidence of can- didemia per 100,000 hospital admissions was calculated from these numbers. Fisher's exact test was used to assess the bivariate relationship between categorical variables-in particular, how clustered isolates were related to other variables. Significance was set at . All tests were 2-tailed. Statistical P ! .05 analysis was performed using SPSS, version 11.0 (SPSS).
RESULTS
Epidemiology.
A description of the study cohort is included in table 1 (table 1) . Yeast isolates were most commonly cultured from patients in ICUs (41.2%). The species and time distribution are shown in figure 1. C. albicans was the most common species, representing 61.6% of the isolates (135 isolates), but there was an increase in isolation of non-C. albicans species toward the end of the study period.
PCR fingerprinting. An overview of the discriminatory power of the different primers is given in table 2. In general, PCR with primers M13 and (GACA) 4 identified the greatest number of genotypes: M13 had the greatest discriminatory power for identifying C. albicans and C. parapsilosis, (GACA) 4 had the greatest power for identifying C. glabrata and C. tropicalis, and both primers identified an equal number of genotypes of Candida dubliniensis. The method was highly reproducible, and ATCC 90028 showed consistent PCR fingerprinting profiles with all 4 primers. Molecular epidemiology. A summary of the molecular epidemiology of bloodstream infections attributable to C. albicans is given in table 3. PCR fingerprinting with the M13 primer revealed 35 different genotypes. The 2 most prevalent genotypes (GT-2 and GT-4) caused 24% of all infections and were endemic during almost the entire study period. GT-32 caused 8% of all infections and was prevalent during 1994-2001 but was not identified after that. Nosocomial clusters. The proportion of infections caused by clustered isolates is summarized in table 4. When 100% similarity for the primer with the greatest discriminatory power was set as the definition of clonality, the proportion was 18.7% (36 cases). When у90% similarity was used as the cutoff, the proportion of candidemia cases caused by strains within the same genotype clusters was 19.7% (38 cases). When the PCR results from all 4 primers were combined and used for analysis, the proportion of infection clusters was 39.9% (77 cases) when у90% similarity was required. With use of 19.7% as a reference, the average rate of cluster-associated cases of candidemia was 11.3 cases per 100,000 hospital admissions per year. Clusters were small; 180% involved 2 cases, and the remainder involved 3 cases.
The time and species distribution of infection clusters is shown in figure 3 . The combined results from all 4 primers revealed a comparable species distribution of clustered BSIs (data not shown). The majority of clustered isolates (22 isolates; 58%) were cultured from samples from patients in ICUs and the NICU, followed by surgery wards (26%), medicine wards (11%), and other wards (5%). The proportion of clustered isolates with the similarity coefficient у90% was significantly higher in wards providing intensive care (i.e., ICUs and the NICU) than in other wards (27% [ NOTE. The number of discriminating bands and the total number of bands are shown. Isolates were considered to be clonal if there was у90% band sharing and concordance between their fingerprinting profiles determined using different primers. Boldface type indicates the primer with the greatest discriminatory power for the respective fungal species.
When different Candida species were compared, the proportion of clustered isolates was highest for C. parapsilosis (31%), which was significantly higher than among other non-C. albicans species (8%;
). For C. albicans, 29 isolates P p .034 (23%) were part of clusters, with 3 genotypes (33 [24% of isolates]) causing 8 (53%) of 15 clusters. GT-2 caused 4 clusters in the study period, and 50% of strains of that genotype were implicated in infection clusters. GT-32 caused 2 clusters during 1994-1995. GT-22 emerged in 2006 and caused 2 clusters of candidemia, 1 in the NICU and 1 in an ICU/surgery ward. All 4 strains of that genotype were part of clusters.
Case fatality. Survival data were available for all but 1 patient (197 patients). During the 16 years of the study, 32 (16%) of the 197 patients died within 7 days and 63 (32%) patients within 30 days after blood samples were obtained for culture. The 7-day and 30-day case-fatality rates for cluster-associated cases did not differ statistically significantly from those of sporadic nosocomial infections.
DISCUSSION
To our knowledge, this is the first long-term, nationwide study of the molecular epidemiology of candidemia. Candida BSIs responsible for 94.4% of all cases of candidemia in Iceland during the 16-year study period were investigated. According to our data, in an unselected hospital population, 18.7%-39.9% of candidemic episodes were caused by nosocomial clusters of infection. The risk of nosocomial clustering was dependent on both the species of the pathogen and the location of the patients. The mean rate of cluster-associated candidemia in Iceland during the 16-year study period was at least 11.3 cases per 100,000 hospital admissions per year. Literature review did not provide comparable information. In comparison, a recent study of outbreak rate of invasive bacterial infections caused by group A streptococci reported 0.5 cases per 100,000 hospital admissions per year [24] . PCR fingerprinting with the 4 single primers provided an effective method for assessing both interspecies and intraspecies genetic variability of the large number of isolates of the different yeast species. The M13 core sequence and the simple repeat sequence (GACA) 4 had the highest discriminatory power for the 5 most common fungal species. Molecular genetic methods have been implemented for genotyping fungal isolates in several other investigations of nosocomial outbreaks. For example, Marco et al. [8] analyzed 110 C. albicans isolates with this method; the isolates were collected from candidemic patients in surgical and neonatal ICUs of 4 hospitals in the United States. They observed a higher degree of clustering of isolates in 3 of 4 hospitals, compared with unrelated control isolates. Other studies have shown that single strains have been responsible for a number of temporally associated outbreaks of candidemia in the same hospital or ICU, which have smoldered over a long period of time, sometimes for years [9, 19, 21, 22, 25] . This is in contrast to common outbreaks of bacterial infections that traditionally have a more abrupt onset and shorter duration [24, [26] [27] [28] .
PCR fingerprinting with the M13 primer revealed 35 different genotypes of C. albicans, 2 of which (GT-2 and GT-4) were endemic throughout most of the study period and caused 5 of 15 clusters. The third most common genotype, GT-32, was prevalent during 1994-2001 but was associated with only 2 clusters. The fourth most common genotype, GT-26, was not associated with any clusters. In 2006, a new distinct genotype, GT-22, was identified that caused 2 clusters in separate hospitals. These results may, therefore, indicate variable density in the environment, transmissibility, or invasive potential. Similarly, Pfaller et al. [29] demonstrated that particular C. albicans BSIs were highly concentrated in particular geographic locales and that established C. albicans strains were endemic in some but not all hospitals, with a possibility of increased risk of candidemia in those settings. For C. parapsilosis, the proportion of clustered isolates was significantly higher than for other non-C. albicans species. An environmental source is more commonly implicated in infection caused by C. parapsilosis, when compared with other Candida species, which could partly explain this difference [11, 30] . It is noteworthy, however, that during the study period, no clusters or outbreaks of candidemia were identified by the hospital surveillance team, underlining the smoldering nature of these infections. Thus, when the characteristics of nosocomial candidemia are taken into account, prospective hospital surveillance with use of molecular typing might be particularly effective for identifying nosocomial clusters.
In this study, the fungal isolates were most commonly detected in culture samples obtained from patients in ICUs, including the NICU, and the proportion of clustered isolates in ICUs was higher than expected (58%). Several reports of outbreaks of candidemia in ICUs and NICUs have been published NOTE. Clusters comprised clonal isolates that were cultured from у2 patients at the same hospital within a period of 90 days. Results for each species are based on PCR fingerprinting with the primer with the greatest discriminatory power for that particular fungal species: M13 for C. albicans, C. parapsilosis, and C. dubliniensis; (GACA) 4 [ 21, 25, 31] . Possible explanations include widespread use of broad-spectrum antibiotics, use of total parenteral nutrition, and intravascular devices in the ICU setting. Furthermore, it has been suggested that frequent contact with patients by hospital personnel facilitates cross-contamination in the ICU [8, 12, 31, 32] .
In the current study, a cluster was defined as isolation of closely related strains (у90% similarity of fingerprinting profiles) from у2 patients at the same hospital within a period of 90 days. No threshold values have been established for cluster analysis by PCR for fungi. The definition of cluster takes into account DNA fingerprinting data from the isolates, as well as temporal-spatial relationships between the patients, but it is still somewhat arbitrary. By fingerprinting C. albicans isolates with the complex probe Ca3, a similarity coefficient (S AB ) of 0.80 has been found to be a reasonable threshold for defining clusters [13] . Furthermore, we may be underestimating the extent of the problem by limiting the definition of clusters to ‫09ע‬ days, because it has been shown that nosocomial outbreaks of Candida infection can persist over a long period of time, even for years [19] [20] [21] .
Fungal bloodstream infections are costly and potentially lethal. The attributable mortality rate associated with candidemia in the United States was recently estimated to be 49% [5] , and the estimated costs attributable to an episode of invasive candidiasis in the United States have been estimated to be $28,000-$48,000 for pediatric and adult patients [33, 34] . Such simple and inexpensive interventions as hand washing, improved skin disinfection, and removal of unnecessary catheters have been shown to dramatically reduce the rate of catheter-related bloodstream infection [35] . In the current study, as many as onethird of all cases of candidemia in an unselected patient population were caused by clusters of epidemiologically and genetically related strains and were therefore potentially preventable. Prevention is the cornerstone to reducing candidemiarelated hospital costs and mortality.
In summary, this study demonstrates that, in an unselected patient population, 18.7%-39.9% of all cases of candidemia are caused by strains that are epidemiologically and genetically related, suggesting that many of the strains have the ability to persist over long periods. Therefore, the clusters lack the general characteristics of nosocomial outbreaks, tend to be unnoticed, and can be identified only by prospective nosocomial surveillance with use of molecular typing. Nosocomial candidemia, therefore, poses new challenges for infection control in hospitals. Prospective studies are needed to identify a source of these infections. Such studies are essential for improving our understanding of these life-threatening-but preventablecomplications of a hospital stay.
